Restoring AS160 phosphorylation rescues skeletal muscle insulin resistance and fatty acid oxidation while not reducing intramuscular lipids

American Journal of Physiology - Endocrinology and Metabolism

Volumn 297, Issue 5, 2009, Pages

  Alkhateeb, Hakam ^a   Chabowski, Adrian ^b   Glatz, Jan F C ^c   Gurd, Brendon ^d   Luiken, Joost J F P ^c   Bonen, Arend ^d  

^a HASHEMITE UNIVERSITY   (Jordan)

^b MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d UNIVERSITY OF GUELPH   (Canada)

Author keywords

Akt; Ceramide; Diacylgycerol; Glucose transporter 4; Palmitate; Triacylglycerol

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; CERAMIDE; DIACYLGLYCEROL; GLUCOSE TRANSPORTER 4; LEPTIN; PALMITIC ACID; PROTEIN KINASE B; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FATTY ACID OXIDATION; GLUCOSE TRANSPORT; INSULIN RESISTANCE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SKELETAL MUSCLE;

ADENYLATE KINASE; AMINOIMIDAZOLE CARBOXAMIDE; ANIMALS; BLOTTING, WESTERN; CELL MEMBRANE; CERAMIDES; FATTY ACIDS; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; GLYCERIDES; GTPASE-ACTIVATING PROTEINS; INSULIN; INSULIN RESISTANCE; LEPTIN; LIPID METABOLISM; MALE; MUSCLE, SKELETAL; ONCOGENE PROTEIN V-AKT; OXIDATION-REDUCTION; PALMITATES; PHOSPHOLIPIDS; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RIBONUCLEOTIDES; STIMULATION, CHEMICAL;

EID: 70350455737     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.90908.2008     Document Type: Article

References (75)

1. Alkhateeb H, Chabowski A, Bonen A. Viability of the isolated soleus muscle during long-term incubation. Appl Physiol Nutr Metab 31: 467-476, 2006. (Pubitemid 44621792)
2. Alkhateeb H, Chabowski A, Glatz JF, Luiken J, Bonen A. Two phases of palmitate-induced insulin resistance in skeletal muscle: impaired GLUT4 translocation is followed by a reduced GLUT4 intrinsic activity. Am J Physiol Endocrinol Metab 293: E783-E793, 2007. (Pubitemid 47358991)
3. Barnes BR, Marklund S, Steiler TL, Walter M, Hjalm G, Amarger V, Mahlapuu M, Leng Y, Johansson C, Galuska D, Lindgren K, Abrink M, Stapleton D, Zierath JR, Andersson L. The 5-AMP-activated protein kinase gamma3 isoform has a key role in carbohydrate and lipid metabolism in glycolytic skeletal muscle. J Biol Chem 279: 38441-38447, 2004. (Pubitemid 39295995)
4. Benton CR, Holloway GP, Campbell SE, Yoshida Y, Tandon NN, Glatz JF, Luiken JJ, Spriet LL, Bonen A. Rosiglitazone increases fatty acid oxidation and fatty acid translocase (FAT/CD36) but not carnitine palmitoyltransferase I in rat muscle mitochondria. J Physiol 586: 1755-1766, 2008.
5. Benton CR, Nickerson JG, Lally J, Han XX, Holloway GP, Glatz JF, Luiken JJ, Graham TE, Heikkila JJ, Bonen A. Modest PGC-1alpha overexpression in muscle in vivo is sufficient to increase insulin sensitivity and palmitate oxidation in subsarcolemmal, not intermyofibrillar, mitochondria. J Biol Chem 283: 4228-4240, 2008.
6. Boden G, Lebed B, Schatz M, Homko C, Lemieux S. Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects. Diabetes 50: 1612-1617, 2001. (Pubitemid 33639602)
7. Bonen A, Chabowski A, Luiken JJ, Glatz JF. Is membrane transport of FFA mediated by lipid, protein, or both? Mechanisms and regulation of protein-mediated cellular fatty acid uptake: molecular, biochemical, and physiological evidence. Physiology (Bethesda) 22: 15-29, 2007.
8. Bonen A, Luiken J, Arumugam Y, Glatz J, Tandon N. Acute regulation of fatty acid uptake involves the cellular redistribution of fatty acid translocase. J Biol Chem 275: 14501-14508, 2000. (Pubitemid 30339737)
9. Bonen A, Luiken JJ, Liu S, Dyck DJ, Kiens B, Kristiansen S, Turcotte LP, Van Der Vusse GJ, Glatz JF. Palmitate transport and fatty acid transporters in red and white muscles. Am J Physiol Endocrinol Metab 275: E471-E478, 1998. (Pubitemid 28436067)
10. Bonen A, Parolin M, Steinberg G, Calles-Escandon J, Tandon N, Glatz J, Luiken J, Heigenhauser G, Dyck D. Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36. FASEB J 18: 1144-1146, 2004. (Pubitemid 39561551)
11. Bruce C, Anderson M, Carey A, Newman D, Bonen A, Kriketos A, Cooney G, Hawley J. Muscle oxidative capacity is a better predictor of insulin sensitivity than lipid status. J Clin Endocrinol Metab 88: 5444-5451, 2003. (Pubitemid 37452752)
12. Bruss M, Arias E, Lienhard G, Cartee G. Increased phosphorylation of Akt substrate of 160 kDa (AS160) in rat skeletal muscle in response to insulin or contractile activity. Diabetes 54: 41-50, 2005. (Pubitemid 40105093)
13. Buettner R, Newgard C, Rhodes C, O'Doherty R. Correction of diet-induced hyperglycemia, hyperinsulinemia, and skeletal muscle insulin resistance by moderate hyperleptinemia. Am J Physiol Endocrinol Metab 278: E563-E569, 2000. (Pubitemid 30149402)
14. Buhl E, Jessen N, Pold R, Ledet T, Flyvbjerg A, Pedersen S, Pedersen O, Schmitz O, Lund S. Long-term AICAR administration reduces metabolic disturbances and lowers blood pressure in rats displaying features of the insulin resistance syndrome. Diabetes 51: 2199-2206, 2002. (Pubitemid 34729025)
15. Buhl E, Jessen N, Schmitz O, Pedersen S, Pedersen O, Holman G, Lund S. Chronic treatment with 5-aminoimidazole-4-carboxamide-1- beta-D-ribofuranoside increases insulin-stimulated glucose uptake and GLUT4 translocation in rat skeletal muscles in a fiber type-specific manner. Diabetes 50: 12-17, 2001. (Pubitemid 32047974)
16. Cartee GD, Wojtaszewski JF. Role of Akt substrate of 160 kDa in insulin-stimulated and contraction-stimulated glucose transport. Appl Physiol Nutr Metab 32: 557-566, 2007.
17. Ceddia R, William WJ, Curi R. Comparing effects of leptin and insulin on glucose metabolism in skeletal muscle: evidence for an effect of leptin on glucose uptake and decarboxylation. Int J Obes Relat Metab Disord 23: 75-82, 1999. (Pubitemid 29008402)
18. Ceddia R, William WJ, Curi R. Leptin increases glucose transport and utilization in skeletal muscle in vitro. Gen Pharmacol 31: 799-801, 1998. (Pubitemid 28520060)
19. Chadt A, Leicht K, Deshmukh A, Jiang LQ, Scherneck S, Bernhardt U, Dreja T, Vogel H, Schmolz K, Kluge R, Zierath JR, Hultschig C, Hoeben RC, Schürmann A, Joost HG, Al-Hasani H. Tbc1d1 mutation in lean mouse strain confers leanness and protects from diet-induced obesity. Nat Genet 40: 1354-1359, 2008.
20. Chavez J, Knotts T, Wang L, Li G, Dobrowsky R, Florant G, Summers S. A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids. J Biol Chem 278: 10297-10303, 2003. (Pubitemid 36800291)
21. Chen ZP, McConell GK, Michell BJ, Snow RJ, Canny BJ, Kemp BE. AMPK signaling in contracting human skeletal muscle: acetyl-CoA carboxylase and NO synthase phosphorylation. Am J Physiol Endocrinol Metab 279: E1202-E1206, 2000.
22. Cho H, Mu J, Kim JK, Thorvaldsen JL, Chu Q, Crenshaw EB 3rd, Kaestner KH, Bartolomei MS, Shulman GI, Birnbaum MJ. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science: 1728-1731, 2001.
23. Cooney GJ, Thompson AL, Furler SM, Ye J, Kraegen EW. Muscle long-chain acyl CoA esters and insulin resistance. Ann NY Acad Sci 967: 196-207, 2002. (Pubitemid 34721906)
24. Dyck DJ, Peters SJ, Glatz J, Gorski J, Keizer H, Kiens B, Liu S, Richter EA, Spriet LL, van der Vusse GJ, Bonen A. Functional differences in lipid metabolism in resting skeletal muscle of various fiber types. Am J Physiol Endocrinol Metab 273: E340-E351, 1997. (Pubitemid 27148735)
25. Dzamko N, Schertzer JD, Ryall JG, Steel R, Macaulay SL, Wee S, Chen ZP, Michell BJ, Oakhill JS, Watt MJ, Jørgensen SB, Lynch GS, Kemp BE, Steinberg GR. AMPK-independent pathways regulate skeletal muscle fatty acid oxidation. J Physiol 586: 5819-5831, 2008.
26. Fediuc S, Gaidhu MP, Ceddia RB. Regulation of AMP-activated protein kinase and acetyl-CoA carboxylase phosphorylation by palmitate in skeletal muscle cells. J Lipid Res 47: 412-420, 2006. (Pubitemid 43276927)
27. Fujii N, Hirshman MF, Kane EM, Ho RC, Peter LE, Seifert MM, Goodyear LJ. AMP-activated protein kinase alpha2 activity is not essential for contraction- and hyperosmolarity-induced glucose transport in skeletal muscle. J Biol Chem 280: 39033-39041, 2005. (Pubitemid 41713853)
28. Funai K, Cartee GD. Inhibition of contraction-stimulated AMP-activated protein kinase inhibits contraction-stimulated increases in PAS-TBC1D1 and glucose transport without altering PAS-AS160 in rat skeletal muscle. Diabetes 58: 1096-1104, 2009.
29. Funai K, Schweitzer GG, Sharma N, Kanzaki M, Cartee GD. Increased AS160 phosphorylation, but not TBC1D1 phosphorylation, with increased postexercise insulin sensitivity in rat skeletal muscle. Am J Physiol Endocrinol Metab 297: E242-E251, 2009.
30. Greco A, Mingrone G, Giancaterini A, Manco M, Morroni M, Cinti S, Granzotto M, Vettor R, Camastra S, Ferrannini E. Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion. Diabetes 51: 144-151, 2002. (Pubitemid 34517991)
31. Hoehn KL, Hohnen-Behrens C, Cederberg A, Wu LE, Turner N, Yuasa T, Ebina Y, James DE. IRS1-independent defects define major nodes of insulin resistance. Cell Metab 7: 421-433, 2008. (Pubitemid 351598028)
32. Holland WL, Brozinick JT, Wang LP, Hawkins ED, Sargent KM, Liu Y, Narra K, Hoehn KL, Knotts TA, Siesky A, Nelson DH, Karathanasis SK, Fontenot GK, Birnbaum MJ, Summers SA. Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metab 5: 167-179, 2007. (Pubitemid 46317299)
33. Holland WL, Knotts TA, Chavez JA, Wang LP, Hoehn KL, Summers SA. Lipid mediators of insulin resistance. Nutr Rev 65: S39-S46, 2007.
34. Holloway GP, Benton CR, Mullen KL, Yoshida Y, Snook LA, Han XX, Glatz JF, Luiken JJ, Lally J, Dyck DJ, Bonen A. In obese rat muscle transport of palmitate is increased and is channeled to triacylglycerol storage despite an increase in mitochondrial palmitate oxidation. Am J Physiol Endocrinol Metab 296: E738-E747, 2009.
35. Houmard JA. Intramuscular lipid oxidation and obesity. Am J Physiol Regul Integr Comp Physiol 294: R1111-R1116, 2008.
36. Hoy AJ, Bruce CR, Cederberg A, Turner N, James DE, Cooney GJ, Kraegen EW. Glucose infusion causes insulin resistance in skeletal muscle of rats without changes in Akt and AS160 phosphorylation. Am J Physiol Endocrinol Metab 293: E1358-E1364, 2007. (Pubitemid 350106605)
37. Hulver M, Berggren J, Cortright R, Dudek R, Thompson R, Pories W, MacDonald K, Cline G, Shulman G, Dohm G, Houmard J. Skeletal muscle lipid metabolism with obesity. Am J Physiol Endocrinol Metab 284: E741-E747, 2003. (Pubitemid 36323867)
38. Iglesias M, Ye J, Frangioudakis G, Saha A, Tomas E, Ruderman N, Cooney G, Kraegen E. AICAR administration causes an apparent enhancement of muscle and liver insulin action in insulin-resistant high-fatfed rats. Diabetes 51: 2886-2894, 2002.
39. Jain S, Glatz JF, Luiken JJ, Bonen A. Regulation of insulin- and contraction-stimuated fatty acid transporters: FAT/CD336, FABppm, FATP1, FATP4 and FATP6 (Abstract). Proceedings of the International Congress on the Biology of Lipids, Maastricht, The Netherlands, 2008.
40. Jessen N, Pold R, Buhl E, Jensen L, Schmitz O, Lund S. Effects of AICAR and exercise on insulin-stimulated glucose uptake, signaling, and GLUT-4 content in rat muscles. J Appl Physiol 94: 1373-1379, 2003. (Pubitemid 36348812)
41. Jørgensen SB, Viollet B, Andreelli F, Frøsig C, Birk JB, Schjerling P, Vaulont S, Richter EA, Wojtaszewski JF. Knockout of the alpha2 but not alpha1 5-AMP-activated protein kinase isoform abolishes 5-aminoimidazole- 4-carboxamide-1-beta-4-ribofuranosidebut not contraction-induced glucose uptake in skeletal muscle. J Biol Chem 279: 1070-1079, 2004. (Pubitemid 38082628)
42. Kahn BB, Alquier T, Carling D, Hardie G. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab 1: 15-25, 2005. (Pubitemid 43960587)
43. Kawanaka K, Han D, Gao J, Nolte L, Holloszy J. Development of glucose-induced insulin resistance in muscle requires protein synthesis. J Biol Chem 276: 20101-20107, 2001. (Pubitemid 37411080)
44. Kelley DE, He J, Menshikova EV, Ritov VB. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51: 2944-2950, 2002.
45. Koistinen HA, Galuska D, Chibalin AV, Yang J, Zierath JR, Holman GD, Wallberg-Henriksson H. 5-amino-imidazole carboxamide riboside increases glucose transport and cell-surface GLUT4 content in skeletal muscle from subjects with type 2 diabetes. Diabetes 52: 1066-1072, 2003. (Pubitemid 36523338)
46. Koves TR, Ussher JR, Noland RC, Slentz D, Mosedale M, Ilkayeva O, Bain J, Stevens R, Dyck JR, Newgard CB, Lopaschuk GD, Muoio DM. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab 7: 45-56, 2008.
47. Kraegen EW, Saha AK, Preston E, Wilks D, Hoy AJ, Cooney GJ, Ruderman NB. Increased malonyl-CoA and diacylglycerol content and reduced AMPK activity accompany insulin resistance induced by glucose infusion in muscle and liver of rats. Am J Physiol Endocrinol Metab 290: E471-E479, 2006. (Pubitemid 43671693)
48. Kramer HF, Taylor EB, Witczak CA, Fujii N, Hirshman MF, Goodyear LJ. Calmodulin-binding domain of AS160 regulates contraction- but not insulin-stimulated glucose uptake in skeletal muscle. Diabetes 56: 2854-2862, 2007. (Pubitemid 350223618)
49. Kramer HF, Witczak CA, Fujii N, Jessen N, Taylor EB, Arnolds DE, Sakamoto K, Hirshman MF, Goodyear LJ. Distinct signals regulate AS160 phosphorylation in response to insulin, AICAR, and contraction in mouse skeletal muscle. Diabetes 55: 2067-2076, 2006. (Pubitemid 44509981)
50. Kramer HF, Witczak CA, Taylor EB, Fujii N, Hirshman MF, Goodyear LJ. AS160 regulates insulin- and contraction-stimulated glucose uptake in mouse skeletal muscle. J Biol Chem 281: 31478-31485, 2006. (Pubitemid 46041412)
51. Luiken JJ, Arumugam Y, Dyck DJ, Bell RC, Pelsers MM, Turcotte LP, Tandon NN, Glatz JF, Bonen A. Increased rates of fatty acid uptake and plasmalemmal fatty acid transporters in obese Zucker rats. J Biol Chem 276: 40567-40573, 2001. (Pubitemid 37373196)
52. McConell GK, Lee-Young RS, Chen ZP, Stepto NK, Huynh NN, Stephens TJ, Canny BJ, Kemp BE. Short-term exercise training in humans reduces AMPK signalling during prolonged exercise independent of muscle glycogen. J Physiol 568: 665-676, 2005.
53. Muoio D, Dohm G, Fiedorek FJ, Tapscott E, Coleman R. Leptin directly alters lipid partitioning in skeletal muscle. Diabetes 46: 1360-1363, 1997. (Pubitemid 27315287)
54. Muoio DM, Dohm GL, Tapscott EB, Coleman RA. Leptin opposes insulin's effects on fatty acid partitioning in muscles isolated from obese ob/ob mice. Am J Physiol Endocrinol Metab 276: E913-E921, 1999.
55. Muoio D, Seefeld K, Witters L, Coleman R. AMP-activated kinase reciprocally regulates triacylglycerol synthesis and fatty acid oxidation in liver and muscle: evidence that sn-glycerol-3-phosphate acyltransferase is a novel target. Biochem J 338: 783-791, 1999. (Pubitemid 29140087)
56. Ng Y, Ramm G, Lopez JA, James DE. Rapid activation of Akt2 is sufficient to stimulate GLUT4 translocation in 3T3-L1 adipocytes. Cell Metab 7: 348-356, 2008.
57. Oakes ND, Cooney GJ, Camilleri S, Chisholm DJ, Kraegen EW. Mechanisms of liver and muscle insulin resistance induced by chronic high-fat feeding. Diabetes 46: 1768-1774, 1997. (Pubitemid 27456409)
58. Olsen G, Hansen B. AMP kinase activation ameliorates insulin resistance induced by free fatty acids in rat skeletal muscle. Am J Physiol Endocrinol Metab 283: E965-E970, 2002. (Pubitemid 35216954)
59. Perdomo G, Commerford SR, Richard AM, Adams SH, Corkey BE, O'Doherty RM, Brown NF. Increased beta-oxidation in muscle cells enhances insulin-stimulated glucose metabolism and protects against fatty acid-induced insulin resistance despite intramyocellular lipid accumulation. J Biol Chem 279: 27177-27186, 2004. (Pubitemid 38812554)
60. Pimenta AS, Gaidhu MP, Habib S, So M, Fediuc S, Mirpourian M, Musheev M, Curi R, Ceddia RB. Prolonged exposure to palmitate impairs fatty acid oxidation despite activation of AMP-activated protein kinase in skeletal muscle cells. J Cell Physiol 217: 478-485, 2008.
61. Pold R, Jensen L, Jessen N, Buhl E, Schmitz O, Flyvbjerg A, Fujii N, Goodyear L, Gotfredsen C, Brand C, Lund S. Long-term AICAR administration and exercise prevents diabetes in ZDF rats. Diabetes 54: 928-934, 2005. (Pubitemid 40446305)
62. Roepstorff C, Thiele M, Hillig T, Pilegaard H, Richter EA, Wojtaszewski JF, Kiens B. Higher skeletal muscle alpha2AMPK activation and lower energy charge and fat oxidation in men than in women during submaximal exercise. J Physiol 574: 125-138, 2006. (Pubitemid 43905802)
63. Singh MK, Krisan AD, Crain AM, Collins DE, Yaspelkis BB 3rd. High-fat diet and leptin treatment alter skeletal muscle insulin-stimulated phosphatidylinositol 3-kinase activity and glucose transport. Metabolism 52: 1196-1205, 2003.
64. Smith AC, Bruce CR, Dyck DJ. AMP kinase activation with AICAR further increases fatty acid oxidation and blunts triacylglycerol hydrolysis in contracting rat soleus muscle. J Physiol 565: 547-553, 2005. (Pubitemid 40872481)
65. Smith AC, Bruce CR, Dyck DJ. AMP kinase activation with AICAR simultaneously increases fatty acid and glucose oxidation in resting rat soleus muscle. J Physiol 565: 537-546, 2005. (Pubitemid 40872480)
66. Steinberg G, Dyck D. Development of leptin resistance in rat soleus muscle in response to high-fat diets. Am J Physiol Endocrinol Metab 279: E1374-E1382, 2000.
67. Steinberg G, Smith A, Wormald S, Malenfant P, Collier C, Dyck D. Endurance training partially reverses dietary-induced leptin resistance in rodent skeletal muscle. Am J Physiol Endocrinol Metab 286: E57-E63, 2004. (Pubitemid 38036610)
68. Steinberg GR, Dyck DJ. Development of leptin resistance in rat soleus muscle in response to high-fat diets. Am J Physiol Endocrinol Metab 279: E1374-E1382, 2000.
69. Steinberg GR, Parolin ML, Heigenhauser GJ, Dyck DJ. Leptin increases FA oxidation in lean but not obese human skeletal muscle: evidence of peripheral leptin resistance. Am J Physiol Endocrinol Metab 283: E187-E192, 2002.
70. Taylor EB, An D, Kramer HF, Yu H, Fujii NL, Roeckl KS, Bowles N, Hirshman MF, Xie J, Feener EP, Goodyear LJ. Discovery of TBC1D1 as an insulin-, AICAR-, and contraction-stimulated signaling nexus in mouse skeletal muscle. J Biol Chem 283: 9787-9796, 2008.
71. Thyfault JP, Cree MG, Zheng D, Zwetsloot JJ, Tapscott EB, Koves TR, Ilkayeva O, Wolfe RR, Muoio DM, Dohm GL. Contraction of insulin-resistant muscle normalizes insulin action in association with increased mitochondrial activity and fatty acid catabolism. Am J Physiol Cell Physiol 292: C729-C739, 2007. (Pubitemid 46263472)
72. Yaspelkis BB 3rd, Davis JR, Saberi M, Smith TL, Jazayeri R, Singh M, Fernandez V, Trevino B, Chinookoswong N, Wang J, Shi ZQ, Levin N. Leptin administration improves skeletal muscle insulin responsiveness in diet-induced insulin-resistant rats. Am J Physiol Endocrinol Metab 280: E130-E142, 2001.
73. Yaspelkis BB 3rd, Singh MK, Krisan AD, Collins DE, Kwong CC, Bernard JR, Crain AM. Chronic leptin treatment enhances insulin-stimulated glucose disposal in skeletal muscle of high-fat fed rodents. Life Sci 74: 1801-1816, 2004.
74. Yu C, Chen Y, Cline GW, Zhang D, Zong H, Wang Y, Bergeron R, Kim JK, Cushman SW, Cooney GJ, Atcheson B, White MF, Kraegen EW, Shulman GI. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 277: 50230-50236, 2002. (Pubitemid 36042170)
75. Zierath J, Frevert E, Ryder J, Berggren P, Kahn B. Evidence against a direct effect of leptin on glucose transport in skeletal muscle and adipocytes. Diabetes 47: 1-4, 1998. (Pubitemid 28030800)